(Q36352928)

13 August 2017

1 reference

title

Essential properties of drug-targeting delivery systems (English)

1 reference

13 August 2017

Karel Petrak

1

1 reference

13 August 2017

publication date

1 December 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

10

1 reference

13 August 2017

issue

23-24

1 reference

13 August 2017

page(s)

1667-1673

1 reference

Some Serum Protein Nitrogen Mustard Complexes with High Chemotherapeutic Selectivity

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Engineering targeted in vivo drug delivery. I. The physiological and physicochemical principles governing opportunities and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Efficiency of drug targeting: steady-state considerations using a three-compartment model

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Interactions of a model block copolymer drug delivery system with two serum proteins and myoglobin

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Factors affecting drug and gene delivery: effects of interaction with blood components

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Long-range and short-range mechanisms of hydrophobic attraction and hydrophilic repulsion in specific and aspecific interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Synthesis and application of a non-viral gene delivery system for immunogene therapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Targeted polymeric micelles for delivery of poorly soluble drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Adsorption of fibrinogen on to polystyrene latex coated with the non-ionic surfactant, poloxamer 338

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Cathepsin K inhibitor-polymer conjugates: potential drugs for the treatment of osteoporosis and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Increased accumulation of PEG-PE micelles in the area of experimental myocardial infarction in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Targeted prodrug treatment of HER‐2‐positive breast tumor cells using trastuzumab and paclitaxel linked by A‐Z‐CINNTM Linker

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Polymerizable phospholipid analogues--new stable biomembrane and cell models

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Nucleosome-releasing treatment makes surviving tumor cells better targets for nucleosome-specific anticancer antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Starlike vs. classic macromolecular prodrugs: two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Targeting of immunoliposomes to endothelial cells using a single-chain Fv fragment directed against human endoglin (CD105).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Tumor specific novel taxoid-monoclonal antibody conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Tumor-Specific Novel Taxoid−Monoclonal Antibody Conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Acid- and salt-triggered multifunctional poly(propylene imine) dendrimer as a prospective drug delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Synthesis of a poly(vinylpyrrolidone-co-dimethyl maleic anhydride) co-polymer and its application for renal drug targeting

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

DE-310, a macromolecular prodrug of the topoisomerase-I-inhibitor exatecan (DX-8951), in patients with operable solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Caelyx (stealth liposomal doxorubicin) in the treatment of advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

Dose dependency of pharmacokinetics and therapeutic efficacy of pegylated liposomal doxorubicin (DOXIL) in murine models

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903698-6

7 January 2021

10.1016/S1359-6446(05)03698-6

Identifiers

DOI

1 reference

13 August 2017

1 reference